Investigational Drug Details
| Drug ID: | D288 |
| Drug Name: | Physostigmine |
| Synonyms: | |
| Type: | small molecule |
| DrugBank ID: | DB00981 |
| DrugBank Description: | A cholinesterase inhibitor that is rapidly absorbed through membranes. It can be applied topically to the conjunctiva. It also can cross the blood-brain barrier and is used when central nervous system effects are desired, as in the treatment of severe anticholinergic toxicity. |
| PubChem ID: | 5983 |
| CasNo: | 57-47-6 |
| Repositioning for NAFLD: | Yes |
| SMILES: | [H][C@]12N(C)CC[C@@]1(C)C1=C(C=CC(OC(=O)NC)=C1)N2C |
| Structure: |
|
| InChiKey: | PIJVFDBKTWXHHD-HIFRSBDPSA-N |
| Molecular Weight: | 275.3461 |
| DrugBank Targets: | Acetylcholinesterase; Neuronal acetylcholine receptor subunit alpha-4; Neuronal acetylcholine receptor subunit beta-2 |
| DrugBank MoA: | Physostigmine inhibits acetylcholinesterase, the enzyme responsible for the breakdown of used acetylcholine. By interfering with the metabolism of acetylcholine, physostigmine indirectly stimulates both nicotinic and muscarinic receptors due to the consequential increase in available acetylcholine at the synapse. |
| DrugBank Pharmacology: | Physostigmine is a parasympathomimetic, specifically, a reversible cholinesterase inhibitor which effectively increases the concentration of acetylcholine at the sites of cholinergic transmission. Physostigmine is used to treat glaucoma. Because it crosses the blood-brain barrier, it is also used to treat the central nervous system effects of atropine overdose and other anticholinergic drug overdoses. Physostigmine can reverse both central and peripheral anticholinergia. |
| DrugBank Indication: | For the treatment of glaucoma, and in the treatment of severe anticholinergic toxicity. |
| Targets: | |
| Therapeutic Category: | |
| Clinical Trial Progress: | |
| Latest Progress: |
| Trial ID | Source ID | Phases | Status | Study Results | Start Date | Last Update Posted |
|---|
| Target ID | Target Name | GENE | Action | Class | UniProtKB ID | Entry Name |
|---|
| Strategy ID | Strategy | Synonyms | Related Targets | Related Drugs |
|---|
| Article ID | PMID | Source | Title |
|---|